COVID-19
Gilead facing criticism for charging $2,340 for remdesivir
June 30, 2020Manufacturing and Production COVID-19, coronavirus
Gilead has announced that it will charge $2,340 for a 5 day treatment course of remdesivir, a drug that has …
Vaxart announces its COVID-19 vaccine has been selected by US Operation Warp Speed programme
June 29, 2020Sales and Marketing COVID-19, COVID-19 vaccine, coronavirus, coronavirus vaccine
Vaxart has announced the selection of its lead vaccine candidate for COVID-19 by Operation Warp Speed, a program to find …
China’s COVID-19 vaccine candidate approved for military use
June 29, 2020Sales and Marketing COVID-19, coronavirus
China’s military have received approval to use a new vaccine candidate for coronavirus after clinical trials proved it was safe …
70% of BAME pharmacists in the UK have had no risk assessment for COVID-19
June 26, 2020Medical Communications COVID-19, coronavirus
More than two thirds of black, Asian and minority ethnic pharmacists have not had any workplace risk assessments for COVID-19, …
Gilead’s remdesivir becomes first EU-recommended therapy for COVID-19
June 26, 2020Medical Communications, Sales and Marketing COVID-19, EU Gilead, remdesivir
In a crucial step amidst the ongoing pandemic, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) …
Top Ten most popular articles on Pharmafile.com this week
June 26, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10
The news this week centres on the pandemic in Europe, with the Independent SAGE group are warning that it is …
AstraZeneca continues to ramp up COVID-19 vaccine production with new CMO partnership
June 25, 2020Manufacturing and Production AstraZeneca, COVID-19, Vaccine
AstraZeneca has continued to build its manufacturing capacity to deliver its COVID-19 vaccine candidate, developed in partnership with the University …
COVID-19 antibody tests are being used by the NHS without proper assessment, experts warn
June 25, 2020Business Services, Research and Development COVID-19, antibodies, antibody, coronavirus
Coronavirus antibody tests that are beginning to be used by NHS and care staff have been distributed without adequate assessment, …
NIH ordered to cancel coronavirus research funding by White House, Dr Fauci tells Congress
June 25, 2020Business Services COVID-19, Fauci, NIH, coronavirus, pandemic
The National Institutes of Health had its funding cut from a research project into bat coronavirus, according its Director Dr …
UK health leaders urge “rapid review” of COVID-19 preparedness as England relaxes lockdown
June 24, 2020Research and Development COVID-19, England, UK, coronavirus
British Prime Minister Boris Johnson announced an extensive rollback of existing lockdown measures to restrict the spread of COVID-19 in …
Pharmafile.com’s weekly COVID-19 news round-up
June 24, 2020Research and Development COVID, COVID-19, coronavirus
Coronavirus news this week sees treatments for existing diseases being tested in COVID-19 patients, with Roche’s rheumatoid arthritis drug Actemra …
Sanofi expects approval for its COVID-19 vaccine by the start of 2021
June 23, 2020Manufacturing and Production COVID-19, coronavirus
Sanofi has said it expects to have its coronavirus vaccine approved by the start of next year which is faster …
Gilead to investigate inhaled formulation of promising COVID-19 therapy remdesivir
June 23, 2020Manufacturing and Production, Research and Development COVID-19, Gilead, remdesivir
Gilead is intent on pushing the applications of its antiviral drug remdesivir after it has shown efficacy in the treatment …
FDA and EMA agree to intensify collaboration during COVID-19 pandemic
June 23, 2020Manufacturing and Production COVID-19, coronavirus
Senior officials from the US Food and Drug Administration and the European Medicines Agency have pledged to continue working closely …
How is COVID-19 impacting the rare disease community?
June 22, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, cambridge rare disease network, pharma, rare disease
The COVID-19 pandemic has altered the life of just about everyone, especially patients in receiving continued treatment and care. But …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
